Increased seizure threshold and severity in young transgenic CRND8 mice

Neuroscience Letters
Robert A Del VecchioLynn A Hyde

Abstract

Reports suggest that Alzheimer's disease (AD) patients show a high life-time prevalence of seizure-like disorders. The transgenic CRND8 (TgCRDN8) is a mouse model of AD-like amyloid pathogenesis that expresses a double-mutant form of human amyloid precursor protein 695 (K670N/M671L and V717F). We have previously reported that post-plaque TgCRND8 mice exhibited a lower threshold to seizure with a more severe seizure type when challenged with pentylenetetrazole (PTZ) intravenously. Here, we now report that pre-plaque TgCRND8 mice also demonstrate an increased sensitivity to PTZ-induced seizures with a more severe seizure type over age-matched littermate controls. A lower threshold and more severe seizure type in TgCRND8 mice prior to and after plaque deposition suggest that this genotype difference may be due to beta-amyloid (Abeta) toxicity rather than plaque formation. Thus, the TgCRND8 mice are not only a model for Abeta production and plaque deposition, but may also be useful for AD associated seizure.

References

Jan 1, 1990·Alzheimer Disease and Associated Disorders·S C RisseM A Raskind
Sep 1, 1986·Neurology·W A HauserV E Anderson
Mar 1, 1972·Electroencephalography and Clinical Neurophysiology·R J Racine
Sep 19, 2001·Journal of Neurology, Neurosurgery, and Psychiatry·N SodeyamaY Komatsuzaki

❮ Previous
Next ❯

Citations

Feb 11, 2009·Archives of Neurology·Jorge J Palop, Lennart Mucke
Oct 31, 2006·Behavior Genetics·Jason L Eriksen, Christopher G Janus
Oct 1, 2010·Reviews in the Neurosciences·Susana Ferrao SantosJean-Noël Octave
May 9, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·William J MeilandtLennart Mucke
Apr 26, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Qiang LiuJie Wu
Jan 14, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Erik D RobersonLennart Mucke
Jul 8, 2009·International Journal of Molecular Sciences·Yahya E ChoonaraSibongile R Sibambo
Nov 3, 2012·Epilepsy Currents·Helen E Scharfman
Mar 3, 2007·Neurobiology of Aging·Dione KobayashiKaren S Chen
Nov 11, 2011·CNS Neuroscience & Therapeutics·Daniel FriedmanNikolaos Scarmeas
Jul 28, 2007·Neurobiology of Disease·Arianna BellucciFiorella Casamenti
Dec 21, 2011·Neurobiology of Disease·Nigel C JonesChristopher M Hovens
Dec 9, 2014·Neuroscience·H A Born
Jun 16, 2010·Neuron·Karen H Ashe, Kathleen R Zahs
Oct 5, 2016·Neurobiology of Aging·Cinzia CostaPaolo Calabresi
Oct 20, 2006·Nature·Jorge J PalopLennart Mucke
Feb 26, 2014·Molecular Medicine Reports·Xiutian SimaChao You
Jul 30, 2020·Acta Neuropathologica·Arne IttnerLars M Ittner
Dec 27, 2016·Frontiers in Molecular Neuroscience·Cara J WestmarkRobert K S Wong
Nov 30, 2018·Molecular Neurobiology·D OurdevSatyabrata Kar
Apr 3, 2021·Frontiers in Cell and Developmental Biology·Lorissa LamoureuxLeon M Tai

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.